Ludwig Knabl

Vienna Consulting Engineers (Austria) — Austria

Medicine · Health Sciences

19h-index855citations64works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(37), COVID-19 Clinical Research Studies(23), Long-Term Effects of COVID-19(8), SARS-CoV-2 detection and testing(7), Animal Virus Infections Studies(6)

Publications50 total

Heritability and Transcriptional Impact of JAK3, STAT5A and STAT6 Variants in a Tyrolean Family
International Journal of Molecular Sciences·2026Open Access
Heritability and transcriptional impact of JAK3, STAT5A and STAT6 variants in a Tyrolean family
2025Open Access
Impact of rare JAK/STAT germline mutations on vaccination-induced innate immune responses in a Tyrolian population
International Journal of Biological Sciences·2025· 2 citedOpen Access
Investigation of the transcriptional impact of rare germline JAK/STAT variants found in a Tyrolean alpine community
BMC Genomics·2025· 2 citedOpen Access
Evaluating Seqstant LiveGene Analysis in real-time assessment of metagenomic next-generation sequencing (mNGS) data from respiratory samples
Infection·2025Open Access
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
Viruses·2024· 3 citedOpen Access
RNA sequencing depth guidelines for the study of alternative splicing
2024· 4 citedOpen Access
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
npj Vaccines·2024· 9 citedOpen Access
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2
Scientific Reports·2024· 9 citedOpen Access
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
2023· 1 citedOpen Access
Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet–Leukocyte Interaction in Severe COVID-19
International Journal of Molecular Sciences·2023· 6 citedOpen Access
Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster
The Journal of Infectious Diseases·2023· 1 citedOpen Access
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2
2023· 2 citedOpen Access
High prevalence group testing in epidemiology with geometrically inspired algorithms
Scientific Reports·2023· 1 citedOpen Access
Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet-Leukocyte Interaction in Severe COVID-19
Preprints.org·2023· 5 citedOpen Access
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Nature Communications·2023· 43 citedOpen Access
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
2023· 5 citedOpen Access
Comprehensive alternative splicing recovery needs 200 million reads
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Molecular biological techniques in infectiology
2023Open Access
Insights into SARS-CoV-2 Immune Responses, Disease Severity, and Optimal Sequencing Depth
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Priscilla A. Furth(28), Hye‐Kyung Lee(27), Lothar Hennighausen(27), Dorotheé von Laer(18), Annika Rössler(14), Janine Kimpel(14), Wegene Borena(12), Norbert Kaiser(11), Mary Walter(10), Barbara Falkensammer(8), Derek J. Smith(8), August Zabernigg(8), Antonia Netzl(7), Andreas Walser(7), Lisa Pipperger(7), Samuel Wilks(6), Yasemin Caf(6), Manuel Wieser(6), Anna Mur(6), Jana Schumacher(6)